![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1 | 4.04858299595 | 2.47 | 2.7 | 2.47 | 74765 | 2.57106501 | CS |
4 | 0.23 | 9.82905982906 | 2.34 | 2.92 | 2 | 146874 | 2.3329757 | CS |
12 | -0.89 | -25.7225433526 | 3.46 | 3.55 | 2 | 182591 | 2.52204703 | CS |
26 | 0.79 | 44.3820224719 | 1.78 | 4.2684 | 1.59 | 167769 | 2.80085301 | CS |
52 | 1 | 63.6942675159 | 1.57 | 4.2684 | 1.35 | 112780 | 2.54669409 | CS |
156 | -0.07 | -2.65151515152 | 2.64 | 4.2684 | 1.02 | 123700 | 2.46702344 | CS |
260 | -1.19 | -31.6489361702 | 3.76 | 5.7 | 1.02 | 392031 | 2.97658519 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions